US SB2252 | 2019-2020 | 116th Congress
Status
Spectrum: Partisan Bill (Democrat 2-0)
Status: Introduced on July 24 2019 - 25% progression, died in committee
Action: 2019-07-24 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on July 24 2019 - 25% progression, died in committee
Action: 2019-07-24 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]
Summary
Expands the purposes for which states may use certain drug pricing information that is disclosed to them by manufacturers through the Medicaid Drug Rebate Program. Specifically, the bill allows states to use such information in furtherance of prescription drug affordability boards or state multi-payer purchasing pools.
Title
Empowering States to Address Drug Costs Act
Sponsors
| Sen. Chris Van Hollen [D-MD] | Sen. Benjamin Cardin [D-MD] |
History
| Date | Chamber | Action |
|---|---|---|
| 2019-07-24 | Senate | Read twice and referred to the Committee on Finance. |
Subjects
Business records
Government information and archives
Health
Health care costs and insurance
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
Government information and archives
Health
Health care costs and insurance
Inflation and prices
Medicaid
Prescription drugs
State and local government operations
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/116th-congress/senate-bill/2252/all-info |
| Text | https://www.congress.gov/116/bills/s2252/BILLS-116s2252is.pdf |
